Pediatrix Medical Group, Inc. (MD) Stock

Pediatrix Medical Group, Inc., along with its subsidiaries, specializes in delivering comprehensive newborn, maternal-fetal, pediatric cardiology, and various pediatric subspecialty care services across the United States and Puerto Rico. The company's extensive range of offerings includes neonatal care services provided by neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. These services are crucial for babies born prematurely or with complications, ensuring specialized clinical care within hospital units dedicated to neonatal care.

In addition to neonatal care, Pediatrix Medical Group excels in maternal-fetal care, offering both inpatient and office-based clinical services to expectant mothers and unborn babies. This care is administered by maternal-fetal medicine subspecialists, obstetricians, maternal-fetal nurse practitioners, certified nurse midwives, ultrasonographers, and genetic counselors, providing comprehensive support throughout pregnancy.

The company also provides pediatric cardiology services encompassing inpatient and office-based care for patients ranging from fetuses to adolescents with congenital heart defects and acquired heart conditions. These services are delivered by affiliated pediatric cardiologists and related clinical professionals, ensuring specialized cardiac care tailored to each patient's unique needs.

Founded in 1979 and headquartered in Sunrise, Florida, Pediatrix Medical Group operates a network that includes approximately 2,700 physicians as of February 2022. Formerly known as MEDNAX, Inc., the company rebranded to Pediatrix Medical Group, Inc. in July 2022 to better reflect its focus on providing exceptional pediatric and maternal-fetal care. With a commitment to excellence and innovation in healthcare delivery, Pediatrix Medical Group continues to play a vital role in enhancing outcomes for newborns, expectant mothers, and pediatric patients nationwide.